每周医刻|商保创新药目录19个品种,全部纳入浙江双通道范围;阿里健康CEO沈涤凡接任董事会主席

财健道
Dec 26, 2025

请将“财健道”设为星标持续关注,不错过好看本周,减重版司美格鲁肽注射液(商品名:诺和盈)心血管适应症上市申请获得中国国家药品监督管理局(NMPA)批准;先声药业发布公告,与Ipsen签订了独家授权许可协议,涉及其开发的抗体药物偶联物SIM0613;12月22日,国家药监局发布关于修订孟鲁司特制剂说明书的公告,要求所有孟鲁司特制剂在说明书上增加关于神经精神不良反应的警示语;12月23日,贵州三力制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10